Skip to content

INtegrated Colonoscopy Improvement Program in Italy

INtegrated Colonoscopy Improvement Program in Italy (INCIPIT)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03661099
Acronym
incipit
Enrollment
21250
Registered
2018-09-07
Start date
2018-08-29
Completion date
2021-12-31
Last updated
2019-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Lesion, Colon Polyp

Brief summary

The Italian Society of Digestive Endoscopy (SIED) and the Italian Association of Gastroenterologists and Hospital Digestive Endoscopists (AIGO) want to develop an effective training program for endoscopists to improve the quality of colonoscopies through careful evaluation of quality indicators and how they can be improved with an appropriate educational program. Primary objective of this study is to evaluate the variation of Polyp Detection Rate (PDR) and Adenoma Detection Rate (ADR) obtained by operators at high and low volume of colonoscopy before and after a training period. Secondary objectives are to compare high and low volume endoscopists' performance before and after training comparing by evaluation of withdrawal time; Number polyps / patient and Number adenomas / patient; the percentage and time of intubation of the cecum, ; patient's pain perception based on the Nurse Assessed Patient Comfort Score (NAPCOMS) scale. The study is structured as follow: * A first phase when all endoscopists collect the results of 200 colonoscopies in an electronic Case Report Form (eCRF) is formed(maximum enrollment period 4 months). * A second phase of training through an e-platform in which the endoscopists are offered with an online refresh reviewing the international standard parameters to perform a quality colonoscopy. Once the final training exam have been passed, the endoscopist will be able to access the third phase * A third phase in which the endoscopists will collect prospectively the colonoscopies they perform in an eCRF (maximum enrollment period 4 months).

Interventions

DIAGNOSTIC_TESTcolonoscopy

endoscopists' performance outcome

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years

Inclusion criteria

* patients between 50 and 75 years old * colonoscopy for cancer screening program, post polypectomy follow up, patients with abdominal symptoms suggestive for colonic pathology.

Exclusion criteria

* patients aged \< 50 or \> 75 yrs * presence of alarm symptoms * American Society of Anesthesiologists (ASA) Classification ≥ 3 * presence of colonic stenosis * previous colonic resection * Presence of diverticulitis * history of Inflammatory Bowel Disease (IBD) * History of polyposis syndrome * Pregnancy or breastfeeding * inability to provide informed consent * Severe cardiovascular illness * contraindication to undergo to sedation * Anticoagulant therapy * Melanosis coli

Design outcomes

Primary

MeasureTime frameDescription
Adenoma detection rate9 monthsto evaluate Adenoma Detection Rate obtained by operators at high and low volume of colonoscopy before and after a training period(ADR)
Polyps detection rate9 monthsto evaluate the variation of Polyp Detection Rate (PDR) obtained by operators at high and low volume of colonoscopy before and after a training period

Secondary

MeasureTime frameDescription
Number adenomas / patient9 monthsNumber of adenomas found in each patient
percentage of intubation of the cecum9 monthspercentage of colonoscopy in which endoscopist reach cecum
Withdrawal time9 monthsto evaluate the amount of time spent viewing during the withdrawal of the scope
patient's pain perception assessed by Nurse Assessed Patient Comfort Score (NAPCOMS)9 monthsevaluate tolerability of colonoscopy. NAPCOMS includes 3 domains: pain, sedation, and a global subjective assessment of tolerability. The pain domain is defined by using the dimensions of intensity (0. None or minimal; 1 mild; 2. Moderate; 3 severe), frequency (0. None; 1. Few 1 or 2 episodes; 2. Several times (3-4 episodes); 3. Frequent); and duration (0. None; 1 short duration; 2 Moderate duration; 3 Long duration). Sedation is rated according to level of consciousness ranging from 0 (wide awake) to 3 (unconscious), whereas the global tolerability score is rated from 0 (very well tolerated) to 3 (poorly tolerated). The overall NAPCOMS was defined as the sum of the severity, frequency, and duration of pain domains. Level of sedation and overall global tolerability ratings were assessed separately A NAPCOMS of 6 or greater corresponded with a patient rating of moderate to severe discomfort.
time of intubation of the cecum9 monthsthe amount of time spent by endoscopist to reach cecum
Number polyps / patient9 monthsNumber of polyps found in each patient

Countries

Italy

Contacts

Primary ContactPier Alberto Testoni, MD
testoni.pieralberto@hsr.it00390226432756

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026